Ark Genomic Revolution UCITS ETF (LON:ARCG)

Assets	81.92M
Expense Ratio	0.79%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+93.28%

Volume	48,032
Open	717.40
Previous Close	719.95
Day's Range	717.40 - 743.90
52-Week Low	354.10
52-Week High	742.35
Beta	n/a
Holdings	32
Inception Date	Apr 12, 2024

About ARCG

AAKG.DE was created on 2024-04-12 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the Fund is to generate long term capital growth (5 years or more)

• Asset Class: Equity
• Category: Theme
• Stock Exchange: London Stock Exchange
• Ticker Symbol: ARCG
• Provider: ARK

Performance

ARCG had a total return of 93.28% in the past year, including dividends. Since the fund's inception, the average annual return has been 36.05%.

Top 10 Holdings

59.14% of assets

Name	Symbol	Weight
Twist Bioscience Corporation	TWST	10.00%
Tempus AI, Inc.	TEM	9.25%
10x Genomics, Inc.	TXG	7.40%
CRISPR Therapeutics AG	CRSP	5.39%
Absci Corporation	ABSI	4.84%
Natera, Inc.	NTRA	4.62%
CareDx, Inc.	CDNA	4.60%
Illumina, Inc.	ILMN	4.54%
Personalis, Inc.	PSNL	4.53%
Eli Lilly and Company	LLY	3.96%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error